Lawson Eng

2.1k total citations
118 papers, 1.1k citations indexed

About

Lawson Eng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Lawson Eng has authored 118 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 16 papers in General Health Professions. Recurrent topics in Lawson Eng's work include Lung Cancer Treatments and Mutations (18 papers), Cancer survivorship and care (16 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Lawson Eng is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cancer survivorship and care (16 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Lawson Eng collaborates with scholars based in Canada, United States and United Kingdom. Lawson Eng's co-authors include Geoffrey Liu, Wei Xu, David P. Goldstein, Steven Habbous, Fei‐Fei Liu, Samir C. Grover, M. Catherine Brown, Alexandre Chan, Jacob F de Wolff and Meredith Giuliani and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lawson Eng

101 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawson Eng Canada 20 470 171 171 145 141 118 1.1k
Nick Ormiston‐Smith United Kingdom 8 567 1.2× 169 1.0× 160 0.9× 114 0.8× 107 0.8× 13 1.1k
Raghib Ali United Arab Emirates 21 366 0.8× 93 0.5× 207 1.2× 105 0.7× 141 1.0× 70 1.2k
Matteo Franchi Italy 18 312 0.7× 140 0.8× 100 0.6× 116 0.8× 91 0.6× 92 1.1k
Amélie Anota France 17 530 1.1× 232 1.4× 172 1.0× 50 0.3× 109 0.8× 111 1.2k
Jon Shelton United Kingdom 11 865 1.8× 193 1.1× 220 1.3× 83 0.6× 74 0.5× 25 1.4k
Bettina F. Drake United States 19 422 0.9× 209 1.2× 265 1.5× 87 0.6× 153 1.1× 70 1.3k
Mandi Yu United States 17 570 1.2× 147 0.9× 147 0.9× 50 0.3× 67 0.5× 44 1.1k
Lorraine Shack Canada 16 686 1.5× 215 1.3× 153 0.9× 111 0.8× 68 0.5× 51 1.3k
Saber Boutayeb Morocco 15 248 0.5× 111 0.6× 263 1.5× 99 0.7× 102 0.7× 106 1.3k
Dean H. Gesme United States 16 727 1.5× 308 1.8× 224 1.3× 119 0.8× 119 0.8× 33 1.4k

Countries citing papers authored by Lawson Eng

Since Specialization
Citations

This map shows the geographic impact of Lawson Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawson Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawson Eng more than expected).

Fields of papers citing papers by Lawson Eng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawson Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawson Eng. The network helps show where Lawson Eng may publish in the future.

Co-authorship network of co-authors of Lawson Eng

This figure shows the co-authorship network connecting the top 25 collaborators of Lawson Eng. A scholar is included among the top collaborators of Lawson Eng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawson Eng. Lawson Eng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Ronald, Anna Basu, David Hui, et al.. (2025). Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis. Supportive Care in Cancer. 33(3). 193–193. 1 indexed citations
2.
Eng, Lawson, William K. Evans, Katherine K. Nishimura, et al.. (2025). The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification. Journal of Thoracic Oncology. 20(10). 1441–1458.
3.
Katzberg, Hans, Vera Bril, Warren Mason, et al.. (2024). Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors. JTO Clinical and Research Reports. 6(5). 100772–100772.
4.
Chan, Alexandre, Lawson Eng, Changchuan Jiang, et al.. (2024). Global disparities in cancer supportive care: An international survey. Cancer Medicine. 13(17). e70234–e70234. 4 indexed citations
5.
Eng, Lawson, Raymond J. Chan, Alexandre Chan, et al.. (2024). Perceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping Survey. JCO Oncology Practice. 20(6). 816–826. 3 indexed citations
6.
Sutradhar, Rinku, Yue Niu, Ning Liu, et al.. (2024). The impact of body mass index (BMI) on overall survival (OS) among patients receiving immune checkpoint inhibitors (ICIs): A population-based study.. Journal of Clinical Oncology. 42(16_suppl). 12041–12041.
7.
Chan, Alexandre, Yu Ke, Mary Anne Tanay, et al.. (2024). Financial Toxicity in Cancer Supportive Care: An International Survey. JCO Global Oncology. 10(10). e2400043–e2400043. 8 indexed citations
8.
Lok, Benjamin H., Andrea Bezjak, Srinivas Raman, et al.. (2024). Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S93–S94.
9.
Feng, Jiao, Katrina Hueniken, Zhenzhen Fan, et al.. (2023). 1353P Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations. Annals of Oncology. 34. S778–S778. 1 indexed citations
10.
Eng, Lawson, Rinku Sutradhar, Yue Niu, et al.. (2023). Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study. Journal of Clinical Oncology. 41(17). 3122–3134. 57 indexed citations
11.
Ramsey, Imogen, Alexandre Chan, Andreas Charalambous, et al.. (2022). Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners’ knowledge, practices, barriers, and facilitators. Supportive Care in Cancer. 30(11). 9379–9391. 19 indexed citations
12.
Bender, Jacqueline L., Katrina Hueniken, Lawson Eng, et al.. (2021). Internet and social media use in cancer patients: association with distress and perceived benefits and limitations. Supportive Care in Cancer. 29(9). 5273–5281. 22 indexed citations
13.
Sayani, Ambreen, Mandana Vahabi, Mary Ann O’Brien, et al.. (2021). Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening. PLoS ONE. 16(5). e0251264–e0251264. 22 indexed citations
14.
Hueniken, Katrina, M. Catherine Brown, Liang Mao, et al.. (2018). MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC. Journal of Thoracic Oncology. 13(10). S420–S421. 1 indexed citations
15.
Mulrennan, Siobhain, Anna Tai, Lawson Eng, et al.. (2018). Clostridium difficile infection in cystic fibrosis patients. Pediatric Pulmonology. 53. 393–393. 2 indexed citations
16.
Hueniken, Katrina, Catherine Labbé, M. Catherine Brown, et al.. (2018). P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment. Journal of Thoracic Oncology. 13(10). S586–S586. 1 indexed citations
17.
Naik, Hiten, Xin Qiu, M. Catherine Brown, et al.. (2016). Socioeconomic Status and Lifestyle Behaviours in Cancer Survivors: Smoking and Physical Activity. Current Oncology. 23(6). 546–555. 37 indexed citations
18.
Eng, Lawson, Abul Kalam Azad, Xin Qiu, et al.. (2015). Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis. 36(9). 956–962. 7 indexed citations
19.
Eng, Lawson, Abul Kalam Azad, Steven Habbous, et al.. (2012). Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis. Clinical Cancer Research. 18(17). 4526–4537. 45 indexed citations
20.
Habbous, Steven, Junxiong Pang, Lawson Eng, et al.. (2012). p53 Arg72Pro Polymorphism, HPV Status and Initiation, Progression, and Development of Cervical Cancer: A Systematic Review and Meta-Analysis. Clinical Cancer Research. 18(23). 6407–6415. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026